Year: 2026
Type: article
Abstract: Immunoglobulin G4-related disease (IgG4-RD) is a chronic fibroinflammatory disorder with a high rate of disease relapse, contributing to fibrosis, organ damage, and cumulative treatment burden. Relapse in IgG4-RD can occur either in previously affected organs or as de novo organ involvement. Recent advances have shown that both innate and adaptive immune responses contribute to disease persistence and relapse. Regarding risk factors, multiple clinical and serological characteristics as well as treatment-related factors have been associated with disease relapse. Therapeutic strategies have consequently evolved from remission induction alone toward relapse prevention and long-term disease control. Maintenance glucocorticoids, conventional immunosuppressive agents, rituximab, and emerging targeted therapies have demonstrated varying degrees of efficacy in reducing recurrence. In this review, we summarize current evidence regarding relapse patterns, underlying mechanisms, risk factors, and therapeutic approaches in IgG4-RD, with the aim of improving relapse prediction and guiding personalized long-term management.
Source: Frontiers in Immunology
Authors: Junyi Ge, Jingyi Xu, Jinxia Zhao
Institution: Peking University Third Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234552788
